Welcome to MyStrategist, the digital home for Market Pathways.

Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Subscribe
View More
View More
Teaser Image
Regulatory & Reimbursement

Pathways Picks September 20: A Busy Week in Medtech Policymaking

  • 6 days ago
  • David Filmore

In a particularly active week of medtech policy updates: The UK launches an accelerated market access pilot pathway; MDR reform efforts pick up; CMS talks coverage reforms on Capitol Hill; FDA is in overdrive, with a barrage of guidance documents and reports on clinical trials, Breakthrough Devices, global harmonization, and more. Plus, updates on eSTAR, EUDAMED, digital health, and artificial wombs.

Subscribe

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Subscribe
View More
View More
Teaser Image
Regulatory & Reimbursement

CMS Plans to Revise National Coverage Prioritization Process, and More From House Hearing

  • 7 days ago
  • David Filmore

A Medicare official said on Capitol Hill today that CMS will propose revisions to its national coverage determination process next year to improve clarity around decisions about which technologies should be considered for coverage. Meanwhile, the agency is hoping to finalize its Transitional Coverage for Emerging Technologies (TCET) plan this year, while lawmakers try to press ahead with MCIT replacement legislation.

Subscribe

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Subscribe
View More
View More
Teaser Image
Regulatory & Reimbursement

Pathways Picks September 20: A Busy Week in Medtech Policymaking

  • 6 days ago
  • David Filmore

In a particularly active week of medtech policy updates: The UK launches an accelerated market access pilot pathway; MDR reform efforts pick up; CMS talks coverage reforms on Capitol Hill; FDA is in overdrive, with a barrage of guidance documents and reports on clinical trials, Breakthrough Devices, global harmonization, and more. Plus, updates on eSTAR, EUDAMED, digital health, and artificial wombs.

Subscribe

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More